Figure 3: NOx and 8-isoprostane of patients in chronic phase.
Reproduced from [21] with permission from © 2006 by Ishiyaku Publishers, Inc., Japan. Data are presented as the mean ± SD. The 8-isoprostane level was notably higher in patients with a history of KD, regardless of whether coronary lesions were present. KD patients also showed a significant reduction in NOx.
Reproduced from [21] with permission from © 2006 by Ishiyaku Publishers, Inc., Japan. Data are presented as the mean ± SD. The 8-isoprostane level was notably higher in patients with a history of KD, regardless of whether coronary lesions were present. KD patients also showed a significant reduction in NOx.
